Finerenone is a non-steroidal mineralocorticoid receptor antagonist indicated to reduce the risk of kidney function decline and cardiovascular events in adults with chronic kidney disease associated with… Read more




























![Chemical structure of 4,4'-((10S)-6-Methyl-1,9-dioxo-3,4,5,8,9,10-hexahydro-1H-pyrano[4,3-b][1,6]naphthyridine-3,10-diyl)bis(3-methoxybenzonitrile)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F44-10S-6-Methyl-19-dioxo-3458910-hexahydro-1H-pyrano43-b16naphthyridine-310-diylbis3-methoxybenzonitrile.png&w=3840&q=75)
![Chemical structure of 4,4'-(6-Methyl-1,9-dioxo-3,4,5,8,9,10-hexahydro-1H-pyrano[4,3-b][1,6]naphthyridine-3,10-diyl)bis(3-methoxybenzonitrile)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F44-6-Methyl-19-dioxo-3458910-hexahydro-1H-pyrano43-b16naphthyridine-310-diylbis3-methoxybenzonitrile.png&w=3840&q=75)
![Chemical structure of 4,6-Dimethylpyrido[4,3-b][1,6]naphthyridine-1,9(2H,8H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F46-Dimethylpyrido43-b16naphthyridine-192H8H-dione.png&w=3840&q=75)



















Finerenone is a non-steroidal mineralocorticoid receptor antagonist indicated to reduce the risk of kidney function decline and cardiovascular events in adults with chronic kidney disease associated with type 2 diabetes. This category features a comprehensive range of Finerenone reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting accurate impurity profiling, method validation, and routine quality control during drug development and manufacturing. By utilizing these precisely characterized compounds, analysts can ensure the reliability of analytical testing procedures, such as high-performance liquid chromatography or mass spectrometry methods. Stable isotope labelled standards act as vital internal controls, enabling precise quantification and consistency throughout the analytical lifecycle. These resources support the rigorous regulatory standards required for maintaining the safety and efficacy of the final pharmaceutical product.